The Leadership Team at Verge Genomics drives the strategic vision and operational execution of the company, leveraging their expertise in medicinal chemistry, operations, and scientific innovation to lead the development of transformative therapies for neurodegenerative diseases. This team collaborates closely to align resources, advance research initiatives, and foster partnerships that accelerate drug development and improve patient outcomes.